Optimization of Radiation Protection Through Genomic Analyses

Recruiting now · Not applicable

Conditions studied: DNA, Cancer, Radiation

In brief

The long-term goal is to define "signatures" in the form of genomic changes through sequence analyses of genomic DNA using modern Next Generation Sequencing (NGS) methods, which 1. determine the radiation exposure of humans. 2. provide information about the exposure (dose). 3. determine the radiation quality. 4. predict the repair capacity and radiation resistance of an individual.

Key facts

Study ID

NCT06253338

Run by

University Hospital, Essen

People needed

30

Starts

2024-06-01

Expected to finish

2030-01-15

Last updated by the study team

2024-09-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ECOG 0/1 no prior treatment no prior cancer diagnosis thoracic or head and neck cancer

You may not qualify if…

• prior treatment (chemotherapy, radiotherapy, etc.) prior cancer diagnosis

Where it is running

• Department for Radiotherapy, University Hospital Essen, National Center for Tumor Diseases (NCT) West — Essen, Germany / NRW, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.